Market Closed -
Other stock markets
|
After market 02:26:09 am | |||
764 USD | +0.83% | 763.2 | -0.10% |
02:36pm | Argus Adjusts Price Target on Eli Lilly to $840 From $770 | MT |
01:33pm | Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.06% | 68TCr | |
+30.35% | 59TCr | |
-3.42% | 36TCr | |
+18.02% | 33TCr | |
+4.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+8.12% | 17TCr | |
-1.42% | 16TCr |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly to Acquire Beam Therapeutics' Opt-In Rights to Verve Therapeutics' Cardiovascular Programs